Article Text

PDF
Ursodeoxycholic acid for primary biliary cirrhosis
  • Relevant BNF section: 1.9.1

Abstract

Primary biliary cirrhosis is a progressive chronic liver disease estimated to affect up to 1 in 4000 people in the UK.1 Patients with end-stage disease or an associated poor quality of life commonly need a liver transplant. Traditionally, drugs have offered little help as their benefits are modest and their unwanted effects unacceptable. Recently, the bile acid ursodeoxycholic acid has been used to treat primary biliary cirrhosis . Here we discuss the place of such therapy.

Statistics from Altmetric.com

  • Relevant BNF section: 1.9.1

View Full Text

Footnotes

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.